The efficacy of continuous consumption of Apple Pectin for the internal exposure (radioactive Cs) reduction: Randamized double-blind trial

The efficacy of continuous consumption of Apple Pectin for the internal exposure (radioactive Cs) reduction: Randamized double-blind trial - Apple pectin trial in Fukushima

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016082

Enrollment

120

Registered

2014-12-29

Start date

2013-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nothing

Interventions

In active group, participants eat the jelly with 1g apple pectin 3 times a day before each meal for 4 weeks. In placebo group, participants eat the placebo jelly 3 times a day before each meal for 4 w

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Employees of Fukushima prefecture companies. (2)Those who have been detected 7500 cpm by whole body counter (WBC) examination after 11 Mar.,2011. (3)Those who can understand the purpose and the contents of this study, and can agree with participation by letter.

Exclusion criteria

Exclusion criteria: (1)The presence of allergic response to apple. (2)Those who have taken medical supplies or supplements which investigator judged that this trial would be affected. (3)Those who are under treatment of severe disease such as cancer. (4)Pregnancy or beast-feeding. (5)In addition, those who were judged inadequate by investigator.

Design outcomes

Primary

Measure	Time frame
The decrease of radioactive Cs	—

Countries

Japan

Contacts

Public ContactTetsu Kinoshita

Community Life Sciences Co., Ltd. Social Epidemiology Institute

tetsu.prospective@gmail.com089-904-7811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026